{
    "SPADE_UN_19320": {
        "Sequence Information": {
            "Peptide Name": "Fusaricidin A/LI-F04a 15",
            "Sequence": "XXVAXNA",
            "Sequence Length": 7,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity.",
                    "Pubmed ID": "22392790",
                    "Reference": "ChemMedChem. 2012;7:871-882",
                    "Author": "Bionda N, Stawikowski M, Stawikowska R, Cudic M, López-Vallejo F, Treitl D, Medina-Franco J, Cudic P",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22392790"
                }
            ],
            "SPADE ID": "SPADE_UN_19320",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_01016",
                    "Similarity": 1.0,
                    "Sequence": "GLKDIFKAGLGSLVKGIAAHVAN"
                },
                {
                    "SPADE_ID": "SPADE_N_01018",
                    "Similarity": 1.0,
                    "Sequence": "GLKEIFKAGLGSLVKGIAAHVAN"
                },
                {
                    "SPADE_ID": "SPADE_N_01022",
                    "Similarity": 1.0,
                    "Sequence": "GLKDIFKAGLGSLVKNIAAHVAN"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Staphylococcus aureus ATCC 33591(MIC=64µg/ml),Staphylococcus epidermidis ATCC 27626(MIC=64µg/ml),Streptococcus pyogenes ATCC 19615(MIC=>64µg/ml),Escherichia coli K-12 ATCC 29181(no activity data),Klebsiella pneumoniae K6 ATCC 700603(no activity data)"
        }
    }
}